Bloom syndrome: research and data priorities for the development of precision medicine as identified by some affected families

被引:13
|
作者
Campbell, Mary Beth [1 ,2 ]
Campbell, Wesley C. [1 ,3 ]
Rogers, James [1 ]
Rogers, Natalie [1 ]
Rogers, Zachary [1 ]
van den Hurk, Anne Marie [1 ]
Webb, Annie [1 ]
Webb, Talon [1 ]
Zaslaw, Paul [1 ]
机构
[1] Childrens Canc Therapy Dev Inst, Pediat Canc Nanocourse 2017, Beaverton, OR 97005 USA
[2] CALTECH, Caltech Off Technol Transfer & Corp Partnerships, Pasadena, CA 91125 USA
[3] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA
来源
关键词
D O I
10.1101/mcs.a002816
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Bloom syndrome (BS) is a rare, autosomal recessive genetic disorder characterized by short stature, a skin rash associated with sun exposure, and an elevated likelihood of developing cancers of essentially all types, beginning at an early age. Cancer is the leading cause of death for persons with BS, and its early onset results in a reported median lifespan of <30 years. With fewer than 300 documented cases since BS was first described in 1954, its rarity has challenged progress in advancing both the care of and the cure for persons with BS. Presently, there are no known clinically actionable targets specific to persons with this cancer predisposition syndrome, despite the fact that standard cancer treatments are often contraindicated or must be substantially modified for persons with BS. Herein, Zachary Rogers recounts his experience as a cancer patient with BS contemplating a substantially customized chemotherapy regimen that highlights the need for development of individualized treatments in the BS community. We also outline a patient-centered research and community action road map with the goal of improving and prolonging the lives of persons with Bloom syndrome, including the facilitation of precision medicine development specific to this condition.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] The United States 2020 Census data: implications for precision medicine and the research landscape
    Roman, Youssef
    PERSONALIZED MEDICINE, 2022, 19 (01) : 5 - 8
  • [32] Precision medicine in acute respiratory distress syndrome: workshop report and recommendations for future research
    Bos, Lieuwe D. J.
    Artigas, Antonio
    Constantin, Jean-Michel
    Hagens, Laura A.
    Heijnen, Nanon
    Laffey, John G.
    Meyer, Nuala
    Papazian, Laurent
    Pisani, Lara
    Schultz, Marcus J.
    Shankar-Hari, Manu
    Smit, Marry R.
    Summers, Charlotte
    Ware, Lorraine B.
    Scala, Raffaele
    Calfee, Carolyn S.
    EUROPEAN RESPIRATORY REVIEW, 2021, 30 (159): : 1 - 11
  • [33] Artificial intelligence in cancer research and precision medicine: Applications, limitations and priorities to drive transformation in the delivery of equitable and unbiased care
    Corti, Chiara
    Cobanaj, Marisa
    Dee, Edward C.
    Criscitiello, Carmen
    Tolaney, Sara M.
    Celi, Leo A.
    Curigliano, Giuseppe
    CANCER TREATMENT REVIEWS, 2023, 112
  • [34] Getting More Precise in Public Messaging on Scientific and Data Uncertainties for Precision Medicine Research
    Ma, Jun
    Kannampallil, Thomas
    ANNALS OF BEHAVIORAL MEDICINE, 2021, 55 (11) : 1045 - 1047
  • [35] The Dutch childhood cancer genome project: Data-driven precision medicine and research
    von Berg, Joanna
    van Belzen, Ianthe A. E. M.
    Wallis, Fleur S. A.
    Spinou, Anastasia
    Farag, Roula
    Cruz, Victoria M.
    Kester, Lennart A.
    Koudijs, Marco
    Baker-Hernandez, John L.
    Janse, Alex
    Badloe, Shashi
    de Vos, Sam
    Santoso, Marcel
    Verwiel, Eugene T. P.
    van Tuil, Mark
    Kerstens, Hindrik H. D.
    Hehir-Kwa, Jayne Y.
    Holstege, Frank C. P.
    Tops, Bastiaan B. J.
    Kemmeren, Patrick
    CANCER RESEARCH, 2024, 84 (17)
  • [36] OncDRS: An integrative clinical and genomic data platform for enabling translational research and precision medicine
    Orechia, John
    Pathak, Ameet
    Shi, Yunling
    Nawani, Aniket
    Belozerov, Andrey
    Fontes, Caitlin
    Lakhiani, Camille
    Jawale, Chetan
    Patel, Chetansharan
    Quinn, Daniel
    Botvinnik, Dmitry
    Mei, Eddie
    Cotter, Elizabeth
    Byleckie, James
    Ullman-Cullere, Mollie
    Chhetri, Padam
    Chalasani, Poornima
    Karnam, Purushotham
    Beaudoin, Ronald
    Sahu, Sandeep
    Belozerova, Yelena
    Mathew, Jomol P.
    APPLIED AND TRANSLATIONAL GENOMICS, 2015, 6 : 18 - 25
  • [37] Returning raw genomic data to research participants in a pediatric cancer precision medicine trial
    Barlow-Stewart, Kristine
    Courtney, Eliza
    Cowley, Mark
    Ebzery, Camron
    Fuentes Bolanos, Noemi
    Gifford, Andrew J.
    Harden, Hazel
    Josephi-Taylor, Sarah
    Kotecha, Rishi S.
    Mateos, Marion K.
    Manzur, Mitali
    Mayoh, Chelsea
    Milnes, Dianne
    Nielsen, Jane
    O'Connor, Matthew
    Padhye, Bhavna
    Pitman, Catherine
    Pitman, Elizabeth
    Pinese, Mark
    Speechly, Catherine
    Sullivan, Ashleigh
    Trahair, Toby
    Tucker, Katherine
    Tyrrell, Vanessa
    Warby, Meera
    Wood, Andrew
    Ziegler, David S.
    Johnston, Carolyn
    NPJ GENOMIC MEDICINE, 2025, 10 (01)
  • [38] Precision Medicine and Big DataThe Application of an Ethics Framework for Big Data in Health and Research
    G. Owen Schaefer
    E Shyong Tai
    Shirley Sun
    Asian Bioethics Review, 2019, 11 : 275 - 288
  • [39] THE TEOTIHUACAN MAPPING PROJECT: EXPERIENCES WITH DATA FILES, BIG QUESTIONS, AND SOME RESEARCH PRIORITIES FOR TEOTIHUACAN
    Cowgill, George L.
    ANCIENT MESOAMERICA, 2015, 26 (01) : 153 - 161
  • [40] Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value
    Chen, Yixi
    Guzauskas, Gregory F.
    Gu, Chengming
    Wang, Bruce C. M.
    Furnback, Wesley E.
    Xie, Guotong
    Dong, Peng
    Garrison, Louis P.
    JOURNAL OF PERSONALIZED MEDICINE, 2016, 6 (04):